By: Rebecca Cerio
Our (bi-, in this case) weekly linkpost, bringing you interesting and informative links on science policy issues buzzing about the internet.
How The Affordable Care Act Will Affect Research – “The key provisions that have a bearing on the lives and work of biomedical researchers include the establishment of a streamlined US Food and Drug Administration pathway for the approval of generic versions of protein-based drugs, so-called biosimilars; the creation of a translational research initiative at the National Institutes of Health called the Cures Acceleration Network; the launch of the Physician Payment Sunshine Act, which would require pharmaceutical and device makers to disclose all payments greater than $10 to physicians, and a push to increase funding for comparative effectiveness research.” (by Bob Grant via The Scientist)
Cancer By The Numbers – A bit of math and a dash of psychology suggests why it is so difficult to make people believe that more disease screening is not always better. I like this article for its very concise description of how a relatively accurate test for a rare disease might give two false positives for every true positive it detects. (by John Allen Paulos via Project Syndicate)
Postdoctoral Researchers—Facts, Trends, and Gaps – Average time to Ph.D., average postdoc length, average salaries…. Finally, we know! Sally Rockey, NIH’s Deputy Director for Extramural Research, discusses some hard numbers on the postdoctoral landscape that have emerged from NIH’s Biomedical Workforce Task Force. She’s also discussed similar types of data from the task force about graduate students on her blog, Rock Talk.
Have an interesting science policy link? Share it in the comments!